$199.50 Million in Sales Expected for Cross Country Healthcare, Inc. (CCRN) This Quarter

Equities research analysts expect Cross Country Healthcare, Inc. (NASDAQ:CCRN) to report $199.50 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Cross Country Healthcare’s earnings. The highest sales estimate is $200.40 million and the lowest is $197.38 million. Cross Country Healthcare posted sales of $204.57 million in the same quarter last year, which suggests a negative year-over-year growth rate of 2.5%. The company is expected to report its next quarterly earnings results on Wednesday, August 7th.

On average, analysts expect that Cross Country Healthcare will report full-year sales of $802.93 million for the current year, with estimates ranging from $795.33 million to $808.44 million. For the next financial year, analysts anticipate that the company will post sales of $835.17 million, with estimates ranging from $809.33 million to $854.03 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Cross Country Healthcare.

Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings data on Wednesday, May 1st. The business services provider reported $0.02 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.06. Cross Country Healthcare had a positive return on equity of 1.19% and a negative net margin of 2.54%. The business had revenue of $195.10 million for the quarter, compared to the consensus estimate of $198.47 million. During the same period in the previous year, the business earned $0.06 earnings per share. The business’s revenue was down 7.2% on a year-over-year basis.

Several equities analysts have recently commented on CCRN shares. BidaskClub downgraded Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a research report on Tuesday, April 23rd. SunTrust Banks downgraded Cross Country Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, February 19th. ValuEngine downgraded Cross Country Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, March 15th. BMO Capital Markets lowered their price objective on Cross Country Healthcare from $10.00 to $8.00 and set a “market perform” rating on the stock in a research report on Thursday, February 28th. Finally, Zacks Investment Research upgraded Cross Country Healthcare from a “strong sell” rating to a “hold” rating in a research report on Friday, May 3rd. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. Cross Country Healthcare has an average rating of “Hold” and a consensus price target of $9.80.

Shares of Cross Country Healthcare stock traded down $0.20 during trading hours on Thursday, hitting $7.23. The company’s stock had a trading volume of 137,400 shares, compared to its average volume of 208,176. Cross Country Healthcare has a 12-month low of $6.75 and a 12-month high of $12.75. The company has a market capitalization of $277.67 million, a price-to-earnings ratio of 60.25, a PEG ratio of 10.88 and a beta of 1.05. The company has a quick ratio of 2.08, a current ratio of 2.08 and a debt-to-equity ratio of 0.35.

Large investors have recently bought and sold shares of the stock. Magnus Financial Group LLC purchased a new stake in shares of Cross Country Healthcare in the fourth quarter worth about $83,000. Oregon Public Employees Retirement Fund purchased a new stake in shares of Cross Country Healthcare in the fourth quarter worth about $101,000. Bank of New York Mellon Corp lifted its position in shares of Cross Country Healthcare by 3.6% in the fourth quarter. Bank of New York Mellon Corp now owns 473,374 shares of the business services provider’s stock worth $3,470,000 after buying an additional 16,299 shares in the last quarter. Tocqueville Asset Management L.P. lifted its position in shares of Cross Country Healthcare by 10.5% in the fourth quarter. Tocqueville Asset Management L.P. now owns 260,150 shares of the business services provider’s stock worth $1,907,000 after buying an additional 24,650 shares in the last quarter. Finally, 22NW LP lifted its position in shares of Cross Country Healthcare by 22.8% in the fourth quarter. 22NW LP now owns 375,758 shares of the business services provider’s stock worth $2,754,000 after buying an additional 69,833 shares in the last quarter. Institutional investors own 93.66% of the company’s stock.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Featured Article: Analyst Ratings Trading

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.